Welcome

to the Torrex Chiesi Group!

Torrex Chiesi Pharma, Vienna based, a member of the Chiesi Group Italy, the regional center for Central and Eastern Europe and the Commonwealth of Independent States.

more about Torrex Chiesi

 

NEWS

March 2009

The Chiesi Group increases turnover of 14,3 % in 2008

Increase almost three times the average growth rate in the European market.

THERAPEUTIC AREAS

Respiratory diseases

Respiratory diseases are becoming increasingly important (allergies, environmentally induced asthma, smoking, etc.). Pulmonary products are one of the main focuses of the Chiesi Group’s development and marketing activities. A highlight in this area was the patenting of respiratory sprays based on a freon-free (Modulite®) technology. The Torrex Chiesi Group’s own product portfolio is being expanded through the addition of Prolastin®, an important drug for a rare genetically-related disorder (alpha1-antitrypsin-deficiency).

go to Therapeutic Areas